Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
When it happened…
Thursday, 15 July 2021
What delegates came to discuss…
This conference will be an opportunity to examine:
- the potential impact of the Procurement Bill to replace EU procurement directives, with aims for streamlining the system, and allowing for greater freedom, transparency, and value for money
- the previous Transforming public procurement green paper, outlining proposals on the future practices of public procurement, and how this aligns with NHS net-zero ambitions for the supply chain
- what can be learned from the experience of commissioning and procurement during the pandemic, as well as government procurement in response to COVID-19, including:
- the impact of current intensified political, policy, and media scrutiny of procurement relating to the NHS
- findings from the NAO’s investigation into how it was conducted
- implications for the NHS, public opinion, and policy
Officials from the Crown Commercial Service; the Department for International Trade; the Department of Health and Social Care; the Health and Safety Executive; the Medicines and Healthcare products Regulatory Agency; the National Audit Office and The Scottish Government.
Representatives from Addleshaw Goddard; Beckton Dickinson; Biomerieux UK; BIVDA; Boehringer Ingelheim; BSO Procurement and Logistics Service; Burges Salmon; Cepheid UK; GlaxoSmithKline; Gloucestershire County Council; Humankind Charity; Launch Diagnostics; LumiraDx; Molnlycke; National Institute for Health Research; NHS Business Services Authority; NHS London Procurement Partnership; NHS National Services Scotland; One Thought Changes All; Osborne Clarke; Owen Mumford; Pfizer; QIAGEN; Roche Diagnostics; Sysmex UK; Terumo; Tosoh Bioscience; Tunstall Healthcare; University of Kent; Virgin Care and Werfen.
Press: Financial Times and Health Service Journal.